会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Space environmentally durable polyimides and copolyimides
    • 空间环保的聚酰亚胺和共聚酰亚胺
    • US20050137383A1
    • 2005-06-23
    • US10988407
    • 2004-11-08
    • John ConnellJoseph SmithPaul HergenrotherKent WatsonCraig Thompson
    • John ConnellJoseph SmithPaul HergenrotherKent WatsonCraig Thompson
    • C08G73/10C08G69/26
    • C08G73/1071C08G73/10C08G73/1014C08G73/1039C08G73/1057C08G73/1067
    • Polyimides displaying low color in thin films, atomic oxygen resistance, vacuum ultraviolet radiation resistance, solubility in organic solvents in the imide form, high glass transition (Tg) temperatures, and high thermal stability are provided. The poly(amide acid)s, copoly(amide acid)s, polyimides and copolyimides are prepared by the reaction of stoichiometric ratios of an aromatic dianhydride with diamines which contain phenylphosphine oxide groups in polar aprotic solvents. Controlled molecular weight oligomeric (amide acid)s and imides can be prepared by offsetting the stoichiometry according to the Carothers equation using excess diamine and endcapping with aromatic anhydrides The polyimide materials can be processed into various material forms such as thin films, fibers, foams, threads, adhesive film, coatings, dry powders, and fiber coated prepreg, and uses include thin film membranes on antennas, second-surface mirrors, thermal optical coatings, and multi-layer thermal insulation (MLI) blanket materials.
    • 提供在薄膜中显示低色的聚酰亚胺,原子氧电阻,真空紫外线辐射抗性,在酰亚胺形式的有机溶剂中的溶解度,高玻璃化转变温度和高热稳定性。 聚(酰胺酸),共聚(酰胺酸),聚酰亚胺和共聚酰亚胺通过芳族二酐与极性非质子溶剂中含有苯基氧化膦基团的二胺的化学计量比的反应来制备。 控制分子量低聚(酰胺酸)和酰亚胺可以通过使用过量的二胺和用芳族酸酐封端根据Carothers方程来抵消化学计量来制备。聚酰亚胺材料可以加工成各种材料形式,例如薄膜,纤维,泡沫, 螺纹,粘合剂膜,涂料,干粉和纤维涂层预浸料,并且包括天线上的薄膜膜,第二表面反射镜,热光学涂层和多层保温(MLI)覆盖材料。
    • 5. 发明申请
    • SYSTEMS AND METHODS FOR IED DESIGN TEMPLATES
    • 用于IED设计模板的系统和方法
    • US20120185436A1
    • 2012-07-19
    • US13006212
    • 2011-01-13
    • Tony J. LeeCraig Thompson
    • Tony J. LeeCraig Thompson
    • G06F17/30
    • G06F17/00G01R19/2513G06F3/00G06F13/00Y02T10/82
    • Disclosed herein are a variety of systems and methods that may be utilized to facilitate the configuration of intelligent electronic devices using design templates. A design template may be configured to make available to the user only particular inputs that might need to be modified for a specific application of the intelligent electronic device. Use of templates, as disclosed herein, may simplify the task of configuring an intelligent electronic device. Data entered by the user may be utilized to generate a plurality of intelligent electronic device settings. According to various embodiments, the data entered by a user may be stored on the intelligent electronic device in an archive file. The archive file may also include other design information that a user may desire to store on the intelligent electronic device.
    • 本文公开了可以利用设计模板来促进智能电子设备的配置的各种系统和方法。 设计模板可以被配置为仅向用户提供对于智能电子设备的特定应用可能需要修改的特定输入。 使用如本文所公开的模板可以简化配置智能电子设备的任务。 可以利用用户输入的数据来生成多个智能电子设备设置。 根据各种实施例,用户输入的数据可以存储在归档文件中的智能电子设备上。 归档文件还可以包括用户可能想要存储在智能电子设备上的其他设计信息。
    • 8. 发明申请
    • Compositions and methods for treating cancer
    • 用于治疗癌症的组合物和方法
    • US20070259956A1
    • 2007-11-08
    • US10556220
    • 2004-05-07
    • Craig ThompsonDaniel BauerGeorgia Hatzivassiliou
    • Craig ThompsonDaniel BauerGeorgia Hatzivassiliou
    • A61K31/215A61K31/21
    • A61K31/34A61K51/0491
    • Methods of treating individuals identified as having cancer using ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. Methods of inducing apoptosis in cancer cells using an ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. Methods of treating an individual who has cancer comprising the steps of identifying the cancer as having a high rate of aerobic glycolysis, and administering an ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. Methods of treating individuals who have cancer using compounds that inhibit the expression of ATP citrate lyase or tricarboxylate transporter are disclosed. Methods of identifying a compound with anticancer activity are disclosed.
    • 公开了使用ATP柠檬酸裂解酶抑制剂和/或三羧酸转运蛋白抑制剂治疗被鉴定为具有癌症的个体的方法。 公开了使用ATP柠檬酸裂解酶抑制剂和/或三羧酸转运蛋白抑制剂诱导癌细胞凋亡的方法。 公开了治疗患有癌症的个体的方法,包括将癌症鉴定为具有高比例的有氧糖酵解的步骤,以及施用ATP柠檬酸裂解酶抑制剂和/或三羧酸转运蛋白抑制剂。 公开了使用抑制ATP柠檬酸裂合酶或三羧酸转运蛋白的表达的化合物治疗患有癌症的个体的方法。 公开了鉴定具有抗癌活性的化合物的方法。